Ginny Kirby

Ginny Kirby

Board Member

Working to advance a wide range of new therapies and technologies to improve patient outcomes has been the focus of Ginny Kirby’s leadership career in the medical device industry for more than 30 years. She has served on global senior management teams for companies ranging from Fortune 500 to early-stage startup, focusing on strategies to establish clinical value and to drive regulatory approvals, reimbursement and market acceptance of new therapies and technologies. Ginny continues to consult with medical device companies, primarily for those in the start-up stage of development, as well as with the Discovery Launchpad, a technology incubator at the University of Minnesota, Office of Technology Commercialization. 

Ginny earned her bachelor’s degree in communication disorders from the University of Minnesota, a master’s degree in audiology and speech sciences from Purdue University and a master’s degree in management of technology from the Carlson School of Management at the University of Minnesota.

Over the expanse of her professional life, Ginny has had the great fortune to partner with leading medical researchers and to focus her passion and effort on designing and executing clinical trials, always with the goal of establishing evidence to deliver new therapies and technologies that improve the lives of patients. Working with the MHIF board affords her the opportunity to contribute to an organization with a powerful mission that aligns well with her personal values and experience. 

Back to Board of Directors

Ginny Kirby
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.